Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma

Overview of attention for article published in Frontiers in oncology, April 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 47 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,807 followers.

PARP Inhibitor Cytotoxicity https://t.co/PI30O4Gxdj, DNA damage response for the treatment of high risk neuroblastoma https://t.co/RRNuRR3RU2 and exploring the synergy between PARP and CHK1 inhibition https://t.co/n0oRx3rgAe. Congratulations to all involve

20 May 2020

Reply Repost Favourite

New research: Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma: Despite intensive multimodal therapy, the survival rate for high risk neuroblastoma (HR-NB) remains https://t.co/gEWpkD66JB #oncology

10 May 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.